NCT05208268View on ClinicalTrials.gov

A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer

CompletedOBSERVATIONAL
Enrollment

676

Participants

Timeline

Start Date

July 23, 2020

Primary Completion Date

September 22, 2022

Study Completion Date

September 22, 2022

Conditions
Stomach UlcerDuodenal Ulcer
Interventions
DRUG

Pariet

Pariet Tablets.

Trial Locations (29)

Unknown

Site #09, Bucheon-si

Site #31, Bucheon-si

Site #24, Dongtan

Site #03, Ilsan

Site #11, Ilsan

Site #17, Incheon

Site #20, Changwon

Site #29, Iksan

Site #19, Cheongju-si

Site #01, Chungju

Site #07, Busan

Site #08, Busan

Site #14, Busan

Site #15, Busan

Site #28, Busan

Site #02, Daegu

Site #23, Daegu

Site #27, Daegu

Site #05, Seoul

Site #06, Seoul

Site #10, Seoul

Site #13, Seoul

Site #16, Seoul

Site #18, Seoul

Site #21, Seoul

Site #22, Seoul

Site #25, Seoul

Site #26, Seoul

Site #30, Seoul

All Listed Sponsors
lead

Eisai Korea Inc.

INDUSTRY

NCT05208268 - A Study of Pariet to Prevent Gastric and Duodenal Ulcer Associated With Low-aspirin in Korean Participants With a History of Gastric and Duodenal Ulcer | Biotech Hunter | Biotech Hunter